MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with A

Agomelatine

Agomelatine 25mg tablets

Use with caution

Stability notes for Agomelatine 25mg tablets

Moisture sensitive medicine. Store in airtight (sealed) MCA. Manufacturer recommends store in original container. No stability data in MCAs available.

Provenance

This recommendation is based on the products Valdoxan 25 mg film-coated tablets (Servier Laboratories Limited) and Agomelatine Zentiva 25mg film-coated tablets (Zentiva).

Suppliers (6) of Agomelatine 25mg tablets
Agomelatine 25mg tablets (A A H Pharmaceuticals Ltd)
Agomelatine 25mg tablets (Alliance Healthcare (Distribution) Ltd)
Agomelatine 25mg tablets (Medihealth (Northern) Ltd)
Agomelatine 25mg tablets (Zentiva Pharma UK Ltd)
Valdoxan 25mg tablets (CST Pharma Ltd)
Valdoxan 25mg tablets (Servier Laboratories Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.